BLOOD COAGULATION POTENTIAL IN PATIENTS WITH MYOCARDIAL INFARCTION AFTER THROMBOLYSIS AND POSSIBILITIES OF ITS CORRECTION USING MAGNETOTHERAPY

Authors:

Abstract:

The purpose of the study was to investigate the magnetotherapy efficacy aimed at blood coagulation potential and fibrinolytic activity improvement in patients with acute myocardial infarction with ST-segment elevation after thrombolysis at the inpatient stage of rehabilitation. 80 patients with acute myocardial infarction with ST-segment elevation were included in the clinical observation. These patients were randomized into 2 groups. Group 1 consisted of 40 patients treated using thrombolytics with adjuvant therapy and standard cardiovascular drugs. Group 2 consisted of 40 patients who were additionally prescribed the course of magnetotherapy. All patients' blood coagulation potential was analyzed, including the coagulative and anticoagulative chains and fibrinolytic activity standardized indexes. The data obtained showed that parameters of hemostasis quickly return to normal values in patients with acute myocardial infarction with ST-segment elevation 2–3 days after thrombolytic therapy and heparin administration that demonstrate combined moderate blood procoagulative system activation against the background of both anticoagulative and fibrinolytic systems reduced activity. The developed tendency to hypercoagulation duration is maintained throughout the entire inpatient period reaching maximum before the patients' discharge. The course of magnetotherapy in the complex treatment of patients with acute myocardial infarction with ST-segment elevation stimulates a favourable impact on hemostasis coagulative and anticoagulative systems imbalance toward its coagulative potential reduction and fibrinolytic activity increase. The authors suppose that the original magnetotherapy method is easy to perform, effective in blood hypercoagulative state reduction, does not induce side effects, and can be recommended to patients with acute myocardial infarction with ST-segment elevation of any age and weight category after thrombolytic therapy.

Keywords:

acute myocardial infarction thrombolysis magnetotherapy blood coagulation blood coagulative and anticoagulative systems fibrinolysis

References:

1. Grigus IM, Brega LB. Fizychna terapiya v kardiolohiyi. Rivne, 2018: 269 [in Ukrainian].
2. Kovalenko VM, Dorogoi AP. Sertsevo-sudynni khvoroby: medychno-sotsialne znachennya ta stratehiya rozvytku kardiolohiyi v Ukrayini. Ukrayinskyy kardiolohichnyy zhurnal. 2016; 3 (Suppl): 5-14. [in Ukrainian].
3. Kovtun GI, OrlovaNM. Smertnist vid khvorob systemy krovoobihu v Ukrayini: medykostatystychnyy analiz yiyi dynamiky ta rehionalnykh osoblyvostey u 2010–2020 rr. Visnyk Vinnytskoho natsionalnoho medychnoho universytetu. 2023; 27(1): 110–118. doi: 10.31393/reports-vnmedical-2023-27(1)-21. [in Ukrainian].
4. Sertsevo-sudynni zakhvoryuvannya. Klasyfikatsiya, standarty diahnostyky ta likuvannya. Pid red. V.M. Kovalenko, M.I. Lutay, Y.M. Sirenko, O.S. Sychov. Kyyiv: MORION, 2021: 320 [in Ukrainian].
5. Terenda NO. Smertnist vid sertsevo-sudynnykh zakhvoryuvan yak derzhavna problema. Visnyk naukovykh doslidzhen. 2015; 4: 11–13 [in Ukrainian].
6. Chereshnyuk GS, Rudenko AA, Palamar IV. Stan natsionalnoyi systemy okhorony zdorovya, priorytetni napryamky podalshoho udoskonalennya yiyi diyalnosti zi spryamuvannyam pershocherhovykh zakhodiv na zberezhennya i zmitsnennya zdorovya naselennya Ukrayiny. Visnyk Vinnytskoho natsionalnoho medychnoho universytetu. 2023; 27(2): 309–312. doi: 10.31393/reports-vnmedical-2023-27(2)-22. [in Ukrainian].
7. Abushabana M, Korashy M, Al-Tahmody K. Left Ventricular Global Longitudinal Strain Following Acute ST-Elevation Myocardial Infarction – A Comparison of Primary Coronary Angioplasty and Tenecteplase-Based Pharmacological Reperfusion Strategy. Heart Views. 2023; 24(2): 98–103. doi: 10.4103/heartviews.heartviews_103_22.
8. Alexiou S, Patoulias D, Theodoropoulos KC, Didagelos M, Nasoufidou A, Samaras A, et al. Intracoronary Thrombolysis in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: an Updated Meta-analysis of Randomized Controlled Trials. Cardiovasc Drugs Ther. 2024; 38(2): 335–346. doi: 10.1007/s10557-022-07402-3.
9. Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A. et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023; 44(38): 3720–3826. doi: 10.1093/eurheartj/ehad191.
10. Helal AM, Shaheen SM, ElhammadyWA, Ahmed MI, Abdel-HakimAS, Allam LE. Primary PCI versus pharmacoinvasive strategy for ST elevation myocardial infarction. Int J Cardiol Heart Vasc. 2018; 21: 87–93. doi: 10.1016/j.ijcha.2018.10.006.
11. Khan JN, Razvi N, Nazir SA, Singh A, Masca NG, Gershlick AH. et al. Prevalence and extent of infarct and microvascular obstruction following different reperfusion therapies in ST-elevation myocardial infarction. J Cardiovasc Magn Reson. 2014; 16(1): 38. doi: 10.1186/1532-429X-16-38.
12. Proctor P, Leesar MA, Chatterjee A. Thrombolytic Therapy in the Current ERA: Myocardial Infarction and Beyond. Curr Pharm Des. 2018; 24(4): 414–426. doi: 10.2174/1381612824666171227211623.
13. Wang S, Zhou X, Huang B, Wang Z, Zhou L, Wang M. et al. Noninvasive low-frequency electromagnetic stimulation of the left stellate ganglion reduces myocardial infarction-induced ventricular arrhythmia. Sci Rep. 2016; 6: 30783. doi: 10.1038/srep30783.
14. Zolotarova NA, Vastyanov RS, Zolotarova KO, Nescoromna NV. Ώ-3 polyunsaturated fatty acids and magnetotherapy combined impact on free radical processes in patients with stable exertional anginaю Acta Balneologica. 2023; 65(4): 249–252. doi: 10.36740/ABAL202304109.
15. Zwolińska J, Kasprzak M, Kielar A, Prokop M. Positive and Negative Effects of Administering a Magnetic Field to Patients with Rheumatoid Arthritis (RA). J Clin Med. 2024; 13(6): 1619. doi: 10.3390/jcm13061619.

Publication:

«World of Medicine and Biology» Vol. 20 No. 90 (2024) , с. 58-63
УДК 614.876:616-055.6:577.122:616-092.4

DOI:

https://doi.org/10.26724/2079-8334-2024-4-90-58-63